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Cone beam computed tomography (CBCT) imaging is commonly requested by dental 
implant surgeons, pre-operatively, for patients being considered for dental implants. 
Incidental maxillary sinus findings often result in otolaryngology (ENT) referral for further 
assessment.  
CBCT findings include transient and benign mucosal changes that may not require any 
intervention and therefore unnecessarily delay implant surgery. 
We aim to define appropriateness criteria for ESS in the management of adult dental 
implant patients with incidental maxillary sinus findings on CBCT and provide guidance to 
both dental implant and ENT surgeons.  
 
Design 




A virtual panel of 13 international experts in ESS.  
 
Participants  
The expert panel completed two rounds of a modified Delphi ranking process for nine 
clinical scenarios, considering various factors affecting decision-making processes. 
 
Main outcome measures 
To define appropriateness criteria for ESS in adult dental implant patients who have 
incidental maxillary sinus findings on CBCT. 
 
Results 
Patients with clinical symptoms and endoscopic findings of chronic rhinosinusitis together 
with an obstructed ostiomeatal complex (OMC) and concentric mucosal thickening of the 
ipsilateral maxillary sinus or pansinusitis were deemed appropriate candidates for ESS prior 
to their dental implant. ESS was not appropriate in asymptomatic patients with a patent 
OMC and mucosal thickening isolated to floor of the ipsilateral maxillary sinus. 




This study has developed and reported a list of appropriateness criteria to offer ESS in adult 






1. CBCT are often performed as part of the pre-operative work-up for dental implants 
patients. 
2. Incidental maxillary sinus findings may result in inappropriate referrals to ENT resulting 
in unnecessary delay to implant surgery. 
3. Patients with clinical symptoms and endoscopic findings of CRS together with an 
obstructed OMC and concentric mucosal thickening of the ipsilateral maxillary sinus or 
pansinusitis are appropriate candidates for ESS prior to their dental implant.  
4. Asymptomatic patients or those symptomatically managed on appropriate medical 
treatment together with a patent OMC and mucosal thickening isolated to floor of the 
ipsilateral maxillary sinus are not appropriate for ESS prior to dental implantation 
5. In uncertain scenarios, such those with symptoms not specific for CRS and unremarkable 
clinical findings on nasoendoscopy but an isolated obstructed OMC together with 
otherwise clear paranasal sinuses should further discussions between ENT and dental 
implant surgeon to decide appropriateness. 
 
INTRODUCTION 
It is estimated that more that 200,000 dental implants are performed per year in the United 
Kingdom (UK) 1. Dental implant surgeons often request cone beam computed tomography 
(CBCT) imaging in patients being considered for dental implants as part of their pre-
operative investigative work-up. CBCT allows for accurate treatment planning, identification 
of anatomical variations, including the inferior alveolar nerve canal, and any irreversible or 
reversible contraindications to dental implantation, such as underlying bone disease or loss 
of bone volume, that may result in dental implant failure 2-4.  
 
Dental implant patients may subsequently be referred for otolaryngology (ENT) assessment 
if sinonasal pathology is seen on these scans, particularly related to the maxillary sinus. 
However, CBCT may also detect transient and benign mucosal changes that do not require 
any intervention and therefore ENT referral may unnecessarily delay implant surgery 4. 
 
The incidental finding of paranasal sinus opacification is very common, affecting up to half 
of patients undergoing CT scanning for other primary reasons, with the majority of these 
cases involving the maxillary sinus 4,5. Incidental maxillary sinus findings can vary from 
physiological mucosal thickening or mucosal retention cysts, to more concerning features of 
solitary polyps or localised sinusitis 6. 
 
The role of Endoscopic Sinus Surgery (ESS), in otherwise asymptomatic patients who are 
undergoing dental implant surgery, is both to delineate the nature of single sinus 
opacification (i.e. to distinguish between benign and malignant disease) and also to address 
underlying sinonasal disease based on an assumption that it may predispose to an increased 
rate of complications and failure of dental implant osseointegration secondary to untreated 
chronic rhinosinusitis (CRS) and pre-existing maxillary sinus disease 7. 
 
The lack of clear appropriate indications for ESS in patients with incidental maxillary sinus 
findings on CBCT contributes to a large variation in clinical practice amongst both ENT 
surgeons and the referring dental implant surgeons.  
A strategy to achieve consensus includes creating appropriateness criteria to help clinicians 
in their decision making process, where ‘appropriateness’ is defined as the balance of 
benefits against harm of a healthcare intervention 8. 
 
We aim to define appropriateness criteria for ESS in management of adult dental implant 
patients with incidental maxillary sinus findings on CBCT and provide guidance to both 
dental implant and ENT surgeons. We aim to improve care standards for these patients by 
creating defined surgical indications. 
 
MATERIALS AND METHODS 
 
Ethical considerations 
The study was registered with our local clinical audit department (ref:11098). 
 
Study design 
The RAND/UCLA appropriateness methodology step-by-step process was used to develop 
and define the appropriateness criteria for endoscopic sinus surgery in management of 
adult dental implant patients with incidental maxillary sinus findings on CBCT (Figure 1) 9. 
 
Review and synthesis of the literature 
The current literature was reviewed and synthesised (see Appendices) 10. With 
appropriateness studies the purpose of the literature review was to allow us to assess the 
current information available on the topic rather than perform a systematic analysis. 
 
Developing definitions 
ESS was defined as a surgical intervention where the paranasal sinuses are opened using 
endoscopes for visualisation and endoscopic instruments. The purpose of surgery is to 
restitute the physiology of the sinonasal tract through creating a sinus cavity incorporating 
the natural ostium and allow adequate sinus ventilation and facilitate both mucociliary 
clearance and delivery of topical intranasal medication 8,11. 
 
The expert panel 
An international panel of 13 experts in ESS were invited to provide an expert panel with 
representation from the United Kingdom, Spain and Australia. Panel members were chosen 
to include those with clinical expertise in ESS, understanding of evidence-based medicine, 
demonstrable research interest and those without a conflict of interest that could influence 
the study outcomes. 
Contact was established to ascertain interest and availability by email, with telephone or 
direct consultation where necessary. We collated information on each member of the panel 
on their job classification, the number of years performing ESS and an approximation of the 
number of ESS performed per year. 
 
The rating process for appropriateness  
The development of appropriateness criteria consisted of two rounds of a modified Delphi 
ranking process, as per the RAND/UCLA appropriateness methodology 9. 
 
Rating appropriateness: First round  
Panellists were initially provided with a literature review on whether maxillary sinus findings 
on CBCT affects dental implants 10. An online questionnaire was created with nine varied 
clinical scenarios, constructed by the senior author, that took into consideration the 
variables considered by surgeons regarding appropriateness for ESS in this patient cohort. 
This included patient demographics, clinical symptoms, findings on nasoendoscopy, status 
of the ostiomeatal complex (OMC), measurements related to maximal mucosal thickening 
and at least one coronal slice of CBCT of the paranasal sinuses at the level of the maxillary 
sinus/OMC. Cases were carefully selected to demonstrate cases with varying degrees of 
mucosal thickening, with or without obstruction of the OMC, with or without accompanying 
symptoms.  
All scenarios were based on actual presentations of patients being considered for dental 
implants that had been referred to our tertiary centre for consideration of ESS prior to 
implantation. CBCT images of referred patients were anonymised prior to presentation to 
the assessors (see Figure 2).  
Using a 9-point Linkert scale, the expert panel was asked to independently state the 
appropriateness to surgically address the maxillary sinus (assuming CT performed after 
appropriate medical therapy, or that symptoms or signs persist after medical treatment 11) 
from the information provided. They were asked to rank appropriateness based on the 
literature review 10, ESS guidelines 11 and their clinical expertise. A ranking of 1 indicated the 
panellist would not perform surgery prior to implantation and would be comfortable for 
patient to proceed with dental implantation. A ranking of 9 indicated that the panellist 
would surgically address the maxillary sinus prior to dental implantation. 
Further information was sought relating to the importance of the following factors in 
guiding their decision making: (1) clinical history; (2) findings on nasoendoscopy; (3) status 
of OMC (obstructed versus patent); (4) degree of maxillary sinus mucosal thickening; (5) 
extent of mucosal thickening (confined to floor of the maxillary sinus versus concentric); (6) 
status of the other paranasal sinuses; and (7) presence of secretions. Panellists were also 
encouraged to provide additional relevant information related to their decision-making 
process through free-text. Panellists were asked to rank their answers irrespective of the 
source of funding (NHS or privately funded).  
After completion of the first round of ranking the panel moderator (NA), who was not 
involved in the ranking process, entered the results into a clinical database and analysed the 
results. 
Appropriateness for proceeding with ESS prior to dental implantation was classified into 
three levels, using the following definitions 9: 
• Appropriate: panel median of 7-9, without disagreement 
• Uncertain: panel median of 4-6; or any median with disagreement 
• Inappropriate: panel median of 1-3, without disagreement 
NB: “Disagreement” for a clinical scenario was classified as when at least 1 panellist rating 
fell in the lowest 3-point region (1-3) and at least one falls in the highest (7-9), regardless of 
the median score 9. 
 
Rating appropriateness: Second round  
A second round was used to focus on scenarios and information where there was 
considerable dispersion in ratings from the first round.  
Panellists were provided with the average ratings for all the scenarios and their individual 
first round ratings. The members of the panel were asked to re-rank cases where consensus 
was not reached in the first round, taking into consideration the group’s first round results. 
The panel were asked, in cases where they disagreed with the majority, to state reasons 
behind their decision to challenge the other panellist’s perspective. After completion of the 
second round, results were entered into a clinical database and analysed by the panel 
moderator (NA).  
 
RESULTS 
The expert panel 
Thirteen members completed both rounds of the ranking process. All 13 classified their job 
title as a specialist rhinologist, with 8/13 (61.5%) having performed ESS for greater than 10 
years. The other 5/13 (38.5%) have been performing ESS for between 5-10 years. The 
majority of the panel (84.6%) perform >100 ESS procedures a year. 
 
Rating appropriateness  
Each member ranked nine clinical scenarios in round 1. After the first round, there were two 
scenarios (22.2%) where there was a disagreement. Both these scenarios went into a 
second round of ranking but still resulted in an uncertain appropriateness for ESS. 
After the two rounds of a modified Delphi ranking process, the expert panel were able to 
reach a consensus on the majority of clinical scenarios identifying both appropriate and 
inappropriate indications to perform ESS in management of adult dental implant patients 
with incidental maxillary sinus findings on CBCT (Table 1). 
 
Appropriateness criteria for ESS 
Patients undergoing dental implantation who have clinical symptoms and endoscopic 
findings of CRS together with an obstructed OMC and concentric mucosal thickening of the 
ipsilateral maxillary sinus or pansinusitis were deemed appropriate candidates for ESS prior 
to their dental implant. The consensus was that the history; nasoendoscopy findings; and 
OMC status were very important when considering ESS. 
 
Inappropriate criteria for ESS 
Our findings summarised that ESS was not appropriate prior to dental implantation if the 
patient is asymptomatic or symptomatically managed on appropriate medical treatment 
together with a patent OMC and mucosal thickening isolated to floor of the ipsilateral 
maxillary sinus. 
 
Uncertain criteria for ESS 
Uncertainty regarding appropriateness to perform ESS occurred in patients with symptoms 
not specific for CRS and unremarkable clinical findings on nasoendoscopy but had an 
isolated obstructed OMC together with otherwise clear paranasal sinuses. The panel noted 
when considering ESS, the degree or mucosal thickening or status of other paranasal sinuses 
was of uncertain importance in the decision-making process. 
 
DISCUSSION 
Summary of current evidence 
Dental implant surgeons often perform CBCT pre-operatively to assess for radiological 
evidence of sinus disease to rule out pre-existing maxillary sinus disease that is thought to 
be associated with an increased rate of post-operative complications 3,4,7. 
 
The incidental finding of sinus opacification is common in patients who undergo CT imaging 
for other primary reasons. One study looking at patients undergoing septoplasty or 
septorhinoplasty noted sinus opacification in nearly 30% of patients, and of these cases over 
two-thirds have evidence of some extent of maxillary sinus opacification 5.  
A recent study, looking at patients undergoing sinus lift and dental implant procedures, 
noted abnormal maxillary sinus findings on imaging in nearly half of cases despite patients 
having no sinonasal symptoms preoperatively 4. The extent and nature of incidental sinus 
opacification covers a spectrum ranging from small cyst to complete sinus opacification 
associated with OMC obstruction. The most common reported incidental radiological 
findings are peripheral mucosal thickening (20.2-37.9%) and sinus floor cyst/polyps (13.1-
22.6%) 4,6,12. Interestingly, however, the OMC was obstructed in only 1% of cases 4. 
 
Although there is a lack of clarity on what constitutes an adequate medical treatment trial, 
the current guidance for ESS with CRS is that it should be considered in those who are 
refractory to medical treatment. The principal aim of surgical intervention with ESS is to 
improve the severity of patients’ symptoms and therefore patients should generally be 
symptomatic unless they have actual or imminent complications 11.  
 
With dental implant surgery the main aim of any surgical intervention would be to treat CRS 
that could potentially lead to an increased rate of dental implant failure or complication 4,7. 
There is currently a lack of clear appropriate indications for ESS in patients with incidental 
maxillary sinus findings on CBCT. 
 
Appropriateness criteria for ESS prior to dental implant surgery 
The RAND/UCLA appropriateness methodology is well described and has previously been 
utilised defining appropriateness criteria for ESS during management of uncomplicated 
adult CRS and adult recurrent acute rhinosinusitis 9,11,13. No such criteria or high-quality 
evidence for the management of our cohort of patients has been described in the literature 
to date.  
Our findings determined that patients who fit the established criteria for ESS in CRS should 
be offered surgical intervention prior to dental implantation 8,11. Similarly, any patient with 
suspected malignant disease or fungal sinusitis should also proceed to ESS 11. The presence 
of pre-operative sinusitis is a strong predictive factor for post-operative sinusitis. Such 
sinusitis should be managed as per current guidelines to reduce risk of potential 
complications post-operatively although a recent meta-analysis demonstrated that pre-
operative sinusitis did not increase likelihood of implant failure 14. 
An important factor identified in determining appropriateness for ESS was the presence of 
OMC obstruction especially when combined with clinical symptoms and endoscopic findings 
of CRS. 
Conversely, patients who were either asymptomatic or symptomatically managed on 
appropriate medical treatment together with a radiological finding of a patent OMC were 
deemed to be inappropriate for ESS prior to dental implantation. Ritter et al. demonstrated 
that both mucosal thickening and OMC/maxillary ostium obstruction were not associated 
with increased post-operative CRS following dental procedures in asymptomatic patients 
and that overall pre-operative CT findings did not correlate with postoperative 
complications or surgical outcomes 4. 
 
The status of the OMC was felt to be of particular importance as it demonstrated that the 
appropriate maxillary sinus mucociliary clearance and ESS would not provide any significant 
added advantage, especially if there was only a minor degree of isolated mucosal 
thickening. The panel commented that in cases where the nasoendoscopy examination was 
normal but the CBCT fit the appropriateness criteria above, there would still be a tendency 
towards surgical intervention, as although cross-sectional imaging provides a “snapshot” 
image, if the patient’s symptoms persist, the state of the maxillary sinus cannot be 
confirmed without further CT imaging. 
Patients with significant maxillary sinus thickening (i.e. involving the majority or all of the 
ipsilateral maxillary sinus versus an isolated polyp/cyst on the floor of the maxillary sinus) 
were deemed more appropriate for surgical intervention. This is in keeping with 
recommendations from a recent cohort study where patients with incurable CRS and large 
polyps or cysts were suggested to have assessment for ESS 12. 
It was noted that the ‘extent’ of mucosal thickening is a subjective measurement and varied 
pneumatisation of the maxillary sinus would alter likelihood of natural ostium obstruction 
with differing extent of mucosal thickening. However, it was felt that the clinician would be 
able to differentiate between minor and significant mucosal thickening. Although maxillary 
mucosal thickening appears to be increased in those with periodontal disease, implant 
success rate has not been demonstrated to be correlated with extent of mucosal thickening 
alone 15. 
 
The presence of mucosal thickening of other sinuses and the presence of secretions were 
deemed to be of uncertain clinical significance in the decision-making process. The expert 
panel commented that the presence of pus rather than mucosal secretion in the middle 
meatus on the side of the proposed dental implant would lead to advice for ESS. Patients 
with pansinusitis should also be managed as per CRS regardless of dental implant 
considerations 11.  
 
There were two cases of uncertain appropriateness that involved patients with symptoms 
not specific to CRS and had unremarkable findings on nasoendosopy but did have an 
obstructed OMC and some minor degree of mucosal thickening. During the second round, 
an increased percentage of the expert panel tended towards offering ESS prior to dental 
implantation, although the criteria for appropriateness was not reached. It was decided by 
the team that a third round of ranking would not add any further clarity on these clinical 
scenarios.  
 
The expert panel commented on the importance of ensuring patients receive appropriate 
topical medical therapy prior to considering surgical intervention especially in uncertain 
cases. Particularly in cases where there is uncertain appropriateness of ESS, it was felt 
important to discuss the case further with the dental implant surgeon. 
Examples of this may include patients with asymptomatic sinus disease or history of failed 
dental implants with previous uncertain appropriateness criteria for ESS prior to implant 
and the patient did not undergo any ESS.  
 
Clinical implications 
Defining appropriateness criteria for ESS in this cohort of patients suggests parameters to be 
applied to future studies looking at the appropriate role of ESS in such patients. 
Dissemination of this information to otolaryngologists, dental implant surgeons and primary 
care physicians will allow for identification of appropriate patients requiring a hospital visit 
to see an otolaryngologist for consideration of ESS. Through definition of the above criteria 
we hope to ensure that future decision-making process are patient-centred and aim to 
reduce unnecessary hospital visits, delays to patient’s dental implant care pathway and 
inappropriate use of hospital resources. 
 
Where dental surgeons feel confident in reviewing the CBCT, they may include the OMC 
within the field of view. In an asymptomatic patient, where mucosal thickening is restricted 
to the floor of the sinus or in the presence of a simple maxillary cyst, and the ipsilateral 
OMC remains patent, implantation may proceed without need for ENT referral. In other 
settings the patient may be referred for further assessment and endoscopy. Transfer of 
relevant imaging will likely facilitate timely decision making and minimise need for further 
scans. 
 
We would recommend in cases of clinical uncertainty the case management options should 
be discussed with the patient and the dental implant surgeon, with specialist 
otolaryngologist input as required. It is important to consider the reasoning behind why the 
patient is having dental implants. Up to 40% of unilateral maxillary sinusitis is odontogenic 
in origin 16. Patients with periapical dental disease can lead to a breach of the Schneiderian 
membrane resulting in inflammatory mucosal disease and subsequent maxillary sinusitis 17.  
Odontogenic sinus disease refractory to treatment with antimicrobial therapy involves 
definitive treatment of the underlying dental pathology. In such patients, dental extraction 
of affected tooth root alone may suffice in managing the sinusitis without the requirement 
of ESS 18,19. 
 
The panel stressed that although a patient may fit the appropriateness criteria for ESS prior 
dental implant surgery, this is not a necessity and cases must undergo the standard patient-
centred informed decision-making processes to ascertain absolute appropriateness. 
 
Challenges, limitations and future studies 
This study was based on the most commonly encountered clinical scenarios and 
presentations. Invariably, there will be clinical situations which fall outside those looked at 
in this study. It is important that ESS is still offered in such clinical scenarios and not under-
utilised if it was felt appropriate after specialist review, even if not falling within the 
appropriateness criteria described. Similarly, patient expectation and personal preference 
should always be involved in any decision-making process surrounding appropriateness for 
any surgical intervention. 
 
As a result of there being a lack of high-quality evidence currently available on this topic, the 
expert panel based the appropriateness criteria on the current available evidence together 
with their own personal experience and expertise. Individual and geographical bias was 
minimised through having an international faculty and thirteen members on the expert 
panel. With time, further high-quality evidence may be published which could potentially 
alter the criteria for appropriateness of ESS in patients planned for dental implant surgery. 
The panel would recommend that further high-quality evidence is created through research 
and that where appropriate further studies are undertaken to maintain an updated 
appropriateness criteria. We would encourage comparative studies looking at outcomes of 
those defined within the appropriate and inappropriate criteria. Future studies should 
ensure that patient reported outcomes measures are integral to reported outcomes. 
 
An important challenge to overcome is the dissemination of the above criteria to dental 
implant surgeons and provide clear understanding of what OMC obstruction is and how to 
interpret it on CBCT.  
 
In the majority of cases, CBCT provides an adequate quality of images to allow for initial 
radiological diagnosis of the maxillary sinus pathology and assessment of the other 
paranasal sinuses. Dental implant surgeons should, however, be made aware of the 
importance of widening the radiological image windows of the CBCT to include the 
ipsilateral OMC and ethmoid sinuses. 
 
The decision making process surrounding whether a ‘functional’ of ‘full’ ESS approach is 
required in such cases is beyond the remit of this study, however, it is likely this is a decision 
to be made by the operating otolaryngologist taking into consideration patient symptoms 
and radiological findings together with the planned dental implant work.  
 
CONCLUSION 
This study has developed and reported a list of appropriateness criteria to offer ESS in adult 
dental implant patients with incidental maxillary sinus findings on CBCT. These criteria were 
based on the best currently available evidence together with the experience and expertise 
from an expert panel of clinicians with specialist knowledge on ESS. 
The criteria described are to be used as a guide for clinicians in when it is appropriate to 
offer ESS prior to dental implant surgery. Absolute decisions regarding proceeding to 
surgery should follow standard patient-centred processes. However, through identification 
of appropriateness criteria we hope to reduce unnecessary hospital visits and delay in 
















1. Ucer C. Educational pathways. Implant essentials. 2014;May 2014. 
2. Tufekcioglu S, Delilbasi C, Gurler G, Dilaver E, Ozer N. Is 2 mm a safe distance from 
the inferior alveolar canal to avoid neurosensory complications in implant surgery? 
Nigerian Journal of Clinical Practice. 2017;20(3):274-277. 
3. Gupta J, Ali SP. Cone beam computed tomography in oral implants. National journal 
of maxillofacial surgery. 2013;4(1):2. 
4. Ritter A, Rozendorn N, Avishai G, Rosenfeld E, Koren I, Soudry E. Preoperative 
Maxillary Sinus Imaging and the Outcome of Sinus Floor Augmentation and Dental 
Implants in Asymptomatic Patients. The Annals of otology, rhinology, and 
laryngology. 2020;129(3):209-215. 
5. Kim SH, Oh JS, Jang YJ. Incidence and Radiological Findings of Incidental Sinus 
Opacifications in Patients Undergoing Septoplasty or Septorhinoplasty. The Annals of 
otology, rhinology, and laryngology. 2020;129(2):122-127. 
6. Pazera P, Bornstein MM, Pazera A, Sendi P, Katsaros C. Incidental maxillary sinus 
findings in orthodontic patients: a radiographic analysis using cone-beam computed 
tomography (CBCT). Orthodontics & craniofacial research. 2011;14(1):17-24. 
7. Kozuma A, Sasaki M, Seki K, Toyoshima T, Nakano H, Mori Y. Preoperative chronic 
sinusitis as significant cause of postoperative infection and implant loss after sinus 
augmentation from a lateral approach. Oral and maxillofacial surgery. 
2017;21(2):193-200. 
8. Rudmik L, Soler ZM, Hopkins C, et al. Defining appropriateness criteria for 
endoscopic sinus surgery during management of uncomplicated adult chronic 
rhinosinusitis: a RAND/UCLA appropriateness study. Rhinology. 2016;54(2):117-128. 
9. Fitch K, Bernstein SJ, Aguilar MD, Burnand B, LaCalle JR. The RAND/UCLA 
appropriateness method user's manual. RAND CORP SANTA MONICA CA;2001. 
10. Parekh K TF, Bast F, Surda P, Roberts D, Hopkins C. A Literature Review to Determine 
whether Maxillary Sinus Findings on Cone Beam CT Imaging affects Dental Implants. 
Rhinology. 2018;56(Supp. 27):745. 
11. Fokkens WJ, Lund VJ, Hopkins C, et al. European Position Paper on Rhinosinusitis and 
Nasal Polyps 2020. Rhinology. 2020;58(Suppl S29):1-464. 
12. Chen YW, Lee FY, Chang PH, et al. A paradigm for evaluation and management of the 
maxillary sinus before dental implantation. The Laryngoscope. 2018;128(6):1261-
1267. 
13. Rudmik L, Beswick DM, Alt JA, et al. Appropriateness Criteria for Surgery in the 
Management of Adult Recurrent Acute Rhinosinusitis. The Laryngoscope. 
2019;129(1):37-44. 
14. Kim JS, Choi SM, Yoon JH, et al. What Affects Postoperative Sinusitis and Implant 
Failure after Dental Implant: A Meta-analysis. Otolaryngology--head and neck 
surgery : official journal of American Academy of Otolaryngology-Head and Neck 
Surgery. 2019;160(6):974-984. 
15. Maska B, Lin G-H, Othman A, et al. Dental implants and grafting success remain high 
despite large variations in maxillary sinus mucosal thickening. International journal 
of implant dentistry. 2017;3(1):1. 
16. Vestin Fredriksson M, Ohman A, Flygare L, Tano K. When Maxillary Sinusitis Does Not 
Heal: Findings on CBCT Scans of the Sinuses With a Particular Focus on the 
Occurrence of Odontogenic Causes of Maxillary Sinusitis. Laryngoscope investigative 
otolaryngology. 2017;2(6):442-446. 
17. Bajoria AA, Sarkar S, Sinha P. Evaluation of odontogenic maxillary sinusitis with cone 
beam computed tomography: A retrospective study with review of literature. 
Journal of International Society of Preventive & Community Dentistry. 2019;9(2):194. 
18. Little RE, Long CM, Loehrl TA, Poetker DM. Odontogenic sinusitis: A review of the 
current literature. Laryngoscope investigative otolaryngology. 2018;3(2):110-114. 
19. Kim SM. Definition and management of odontogenic maxillary sinusitis. Maxillofacial 









































Figure 1: Flowchart demonstrating RAND/UCLA appropriateness methodology. 
 
Figure 2: An example of a clinical scenario with relevant information provided to the expert 
panel for rating appropriateness for ESS prior to dental implant surgery. 
 
